Krausz M M, Bashenko Y, Hirsh M
Department of General Surgery, Laboratory for Shock and Trauma Research, Rambam Medical Center, Haifa, Israel.
Shock. 2001 Nov;16(5):383-8. doi: 10.1097/00024382-200116050-00011.
Using a standardized massive splenic injury (MSI) model of uncontrolled hemorrhagic shock we studied the effect of vigorous crystalloid or colloid fluid resuscitation on the hemodynamic response, and survival in rats. The value of massive fluid infusion in uncontrolled hemorrhagic shock following intra-abdominal solid organ injury is still controversial. The effect of crystalloid and colloid infusion was studied following massive splenic injury. The animals were randomized into six groups: group 1 (n = 8) sham-operated, group 2 (n = 12) MSI untreated, group 3 (n = 10) MSI treated with 41.5 mL/kg Ringer's lactate (large-volume Ringer's lactate, LVRL), group 4 (n = 14) MSI treated with 5 mL/kg 7.5% NaCl (hypertonic saline, HTS), group 5 (n = 10) MSI treated with 7.5 mL/kg hydroxyethyl starch (HES-7.5), and group 6 (n = 11) MSI treated with 15 mL/kg hydroxyethyl starch (HES-15). Following MSI mean arterial pressure (MAP) in untreated group 2 decreased from 109.1 +/- 4.5 to 49.8 +/- 9.6 mmHg (P < 0.001) in 60 min. Mean survival time was 132.1 +/- 18.7 min, and total blood loss was 30.2 +/- 4.1% of blood volume. LVRL infusion resulted in an early rise in MAP from 59.7 +/- 7.3 to 90.0 +/- 11.3 mmHg (P < 0.01), which then rapidly dropped to 11.7 +/- 4.5 mmHg (P < 0.001) after 60 min. The mean survival time was 82.5 +/- 18.2 min (P < 0.01), and total blood loss was 53.7 +/- 2.9% (P < 0.01). Total blood loss following HTS infusion was 32.2 +/- 4.0% and survival time was 127.9 +/- 19.7 min. HES-7.5 infusion only moderately increased bleeding to 44.2 +/- 3.9% (P < 0.05), but mortality remained unchanged. HES-15 infusion resulted in an increase in blood loss to 47.8 +/- 7.1% (0.01), survival time dropped to 100.7 +/- 12.3 min (P < 0.05). Vigorous large volume infusion of Ringer's lactate or HES following MSI resulted in a significant increase in intra-abdominal bleeding and shortened survival time compared to untreated, small volume HTS, or HES-7.5-treated animals. The hemodynamic response to crystalloid or colloid infusion in blunt abdominal trauma is primarily dependent on the severity of injury and the rate of fluid resuscitation.
我们使用标准化的非控制性出血性休克大鼠严重脾损伤(MSI)模型,研究了积极的晶体液或胶体液复苏对血流动力学反应及大鼠存活率的影响。腹腔实质性器官损伤后进行大量液体输注在非控制性出血性休克中的价值仍存在争议。我们研究了严重脾损伤后晶体液和胶体液输注的效果。将动物随机分为六组:第1组(n = 8)为假手术组,第2组(n = 12)为未治疗的MSI组,第3组(n = 10)为用41.5 mL/kg乳酸林格液治疗的MSI组(大容量乳酸林格液,LVRL),第4组(n = 14)为用5 mL/kg 7.5%氯化钠治疗的MSI组(高渗盐水,HTS),第5组(n = 10)为用7.5 mL/kg羟乙基淀粉治疗的MSI组(HES - 7.5),第6组(n = 11)为用15 mL/kg羟乙基淀粉治疗的MSI组(HES - 15)。在MSI后,未治疗的第2组平均动脉压(MAP)在60分钟内从109.1±4.5 mmHg降至49.8±9.6 mmHg(P < 0.001)。平均存活时间为132.1±18.7分钟,总失血量为血容量的30.2±4.1%。输注LVRL导致MAP早期从59.7±7.3 mmHg升至90.0±11.3 mmHg(P < 0.01),但60分钟后迅速降至11.7±4.5 mmHg(P < 0.001)。平均存活时间为82.5±18.2分钟(P < 0.01),总失血量为53.7±2.9%(P < 0.01)。输注HTS后的总失血量为32.2±4.0%,存活时间为127.9±19.7分钟。输注HES - 7.5仅使出血量适度增加至44.2±3.9%(P < 0.05),但死亡率未变。输注HES - 15导致失血量增加至47.8±7.1%(P < 0.01),存活时间降至100.7±12.3分钟(P < 0.05)。与未治疗、小剂量HTS或HES - 7.5治疗的动物相比,MSI后积极大量输注乳酸林格液或HES导致腹腔内出血显著增加,存活时间缩短。钝性腹部创伤中对晶体液或胶体液输注的血流动力学反应主要取决于损伤的严重程度和液体复苏的速度。